When skincare products refer to copper peptides, they are typically referring to GHK-Cu or a related copper-binding peptide complex
The peptide has not received approval from Health Canada for therapeutic use in humans
Despite advancements in peptide research, several limitations remain
KPV distinguishes KLOW from GLOW
Continuous use makes sense for users still experiencing ongoing improvements without plateau suggesting continued benefit from sustained application, highly satisfied with current results wanting to maintain peak benefits without decline risk, financially comfortable with indefinite product investment as skincare priority, psychologically comfortable with long-term commitment to effective treatment, experiencing rapid benefit decline during previous break attempts indicating necessity of ongoing application, and prioritizing maximum results over cost optimization or flexibility concerns

Collagen is the primary structural protein responsible for: Skin firmness Elasticity Tendon strength Ligament integrity Joint support Healthy fascia Blood vessel structure As collagen declines with age, the body becomes more vulnerable to: Wrinkles Skin laxity Tendon injuries Poor wound healing Ligament weakness Reduced tissue resilience Research suggests GHK-Cu may stimulate fibroblasts the cells responsible for producing collagen, elastin, and components of the extracellular matrix